On January 29, 2024, Carmat SA closed the transaction. The company has now issued 4,140,000 common shares at a price of ?3.99 per share for gross proceeds of ?16,518,600.
Market Closed -
Other stock markets
|
After market 19:39:05 | |||
4.07 EUR | +14.33% | 4.07 | 0.00% |
05-06 | Carmat: progress in ongoing clinical study | CF |
05-06 | CARMAT Continues to Build on Its Momentum in the EFICAS Study | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.25% | 95.1M | |
+9.92% | 127B | |
-6.58% | 10.91B | |
+2.70% | 9.24B | |
-19.55% | 7.44B | |
+34.77% | 5.44B | |
+8.24% | 3.44B | |
-8.32% | 2.87B | |
-5.57% | 2.25B | |
-0.60% | 2.23B |
- Stock Market
- Equities
- ALCAR Stock
- News CARMAT
- Carmat SA announced that it has received ?16.5186 million in funding